Abstract
Changes of biomarkers measured soon after heart transplantation (HTx) can reflect different processes: cardiomyocyte necrosis (troponins, high-sensitivity cardiac TnT and TnI), heart function (natriuretic peptides, BNP and NT-proBNP), fibrosis (galectin-3 and ST2), and global cardiorenal risk (cystatin C). We assessed the prognostic role of hsTnT, NT-proBNP, galectin-3 and cystatin C during the early post-transplant period. A total of 121 consecutive post-HTx patients were assessed. The main outcomes were survival, left ventricular ejection fraction (LVEF) and rejection periods. Survival was assessed after intermediate (12 months) and long periods (total follow-up during study, median of survival 763 days, IR 527-1038 days). LVEF was assessed 12 months after HTx. Rejection was evaluated during follow-up. We report biomarker concentrations measured 10 days and 12 months after HTx. Ten days after HTx, cystatin C and hsTnT predicted death both under univariable and multivariable analysis. These two biomarkers along with galectin-3 were increased in patients with decreased LVEF measured 1 year after HTx. NT-proBNP did not show early prognostic power. None of the measured biomarkers predicted rejection, but hsTnT and NT-proBNP were ...Continue Reading
References
Feb 28, 1996·Statistics in Medicine·F E HarrellD B Mark
May 3, 2003·European Heart Journal·F RoquesS A M Nashef
Nov 22, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Susan StewartMargaret E Billingham
Aug 29, 2009·Clinical Chemistry·Nevio TaglieriJuan Carlos Kaski
Feb 5, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Dirk J A LokDirk J van Veldhuisen
Apr 29, 2010·Current Heart Failure Reports·Rudolf A de BoerDirk J van Veldhuisen
Dec 30, 2010·Annals of Medicine·Rudolf A de BoerDirk J van Veldhuisen
May 24, 2011·The American Journal of Cardiology·W H Wilson TangAllan L Klein
Nov 24, 2011·Clinical Chemistry·E Wilson GrandinDavid A Morrow
May 23, 2012·European Heart Journal·John J V McMurrayUNKNOWN ESC Committee for Practice Guidelines
Jan 1, 2013·Current Opinion in Cardiology·Yingwei LiuGirish Dwivedi
Jan 10, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Patrick T O'GaraUNKNOWN Society for Cardiovascular Angiography and Interventions
May 7, 2013·Current Cardiology Reports·Punam ChowdhuryAlan Maisel
May 8, 2013·European Journal of Heart Failure·Rudolf A de BoerBurkert Pieske
May 28, 2013·Atherosclerosis·Rainer P WoitasHubert Scharnagl
Jun 5, 2013·Annals of Internal Medicine·Paul E Stevens, Adeera Levin
Nov 23, 2013·Annals of Transplantation : Quarterly of the Polish Transplantation Society·Andres Beiras-FernandezSimone Kreth
Jan 22, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·David C GazePaul O Collinson
May 3, 2014·Cardiovascular Drugs and Therapy·Rudolf A de BoerAlan Maisel
Jun 4, 2014·American Heart Journal·Wouter C MeijersRudolf A de Boer
Jun 24, 2014·JACC. Heart Failure·Tariq AhmadG Michael Felker
Jul 12, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Janka FranekováAntonín Jabor
Citations
Nov 5, 2016·JACC. Heart Failure·Alan MaiselWilliam Stendardi
Nov 20, 2016·Clinical Transplantation·Janka FranekováAntonín Jabor
Apr 26, 2018·BioMed Research International·Shihui FuLeiming Luo
Dec 10, 2019·Clinical Transplantation·Aws AlmuflehSharon Chih
Dec 6, 2017·International Journal of Molecular Medicine·Rui DongHui Yuan
Oct 17, 2020·Indian Journal of Thoracic and Cardiovascular Surgery : Official Organ, Association of Thoracic and Cardiovascular Surgeons of India·Jignesh K Patel
Jul 10, 2018·ACS Applied Materials & Interfaces·Emiliano N PrimoGustavo A Rivas